Form 8-K

8-K — RETRACTABLE TECHNOLOGIES INC

Accession: 0001104659-26-097353

Filed: 2026-08-14

Period: 2026-08-14

CIK: 0000946563

SIC: 3841 (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — tm2623222d1_8k.htm (Primary)

EX-99 — EXHIBIT 99 (tm2623222d1_ex99.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2623222d1_8k.htm · Sequence: 1

false

0000946563

2026-08-14

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities

Exchange Act of 1934

Date

of Report (Date of earliest event reported)

August 14, 2026

Retractable Technologies, Inc.

(Exact name of registrant

as specified in its charter)

Texas

001-16465

75-2599762

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

511

Lobo Lane, Little

Elm, Texas

75068-5295

(Address of principal executive

offices)

(Zip Code)

Registrant's

telephone number, including area code

(972)

294-1010

None

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General

Instruction A.2. below):

¨ Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock

RVP

NYSE

American

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ¨

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

Item 8.01 Other Events.

On August 14, 2026, the Company issued a press

release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing results for the periods ended June 30, 2026.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99 Press release announcing results for the periods ended June 30, 2026.

104 Cover Page Interactive Date File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

DATE: August 14, 2026

RETRACTABLE TECHNOLOGIES, INC.

(Registrant)

BY:

/s/ John W. Fort III

JOHN W. FORT III

VICE PRESIDENT, CHIEF FINANCIAL OFFICER, AND CHIEF ACCOUNTING OFFICER

EX-99 — EXHIBIT 99

EX-99

Filename: tm2623222d1_ex99.htm · Sequence: 2

Exhibit 99

RETRACTABLE TECHNOLOGIES, INC. RESULTS

FOR THE PERIODS ENDED JUNE 30, 2026

LITTLE ELM, TEXAS, August 14, 2026 —

Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the second quarter of 2026 and an

operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $10.4 million and an operating

loss of $5.1 million. For the first half of the year, net sales were $14.4 million and operating losses were $11.3 million as compared

to 2025 net revenues of $18.7 million and operating losses of $9.8 million.

While the majority of flu season sales typically

occur in the third quarter, in 2025, purchasing patterns differed with unusually high unit sales related to flu season products in the

second quarter of 2025, impacting comparability to second quarter 2026 unit sales related to flu season products, which follows a more

traditional purchasing pattern.

Domestic production increased to 42.4% of the

units manufactured during the first six months of 2026 compared to 38% of units produced domestically for the first six months of 2025.

Additionally, as previously reported, a reduction in force in April 2026 is expected to result in cost savings in future periods.

Our net income (loss) for the three and six months

ended June 30, 2026 was $2.8 million and $(1.4) million, respectively, including a $6.4 million gain on the sale of equity securities

in the second quarter of 2026.

Comparison of Three Months Ended June 30,

2026 and June 30, 2025

Domestic sales accounted for 81.6% and 81.3% of

total revenues for the three months ended June 30, 2026 and 2025, respectively. Domestic revenues decreased 30.8%, while domestic

unit sales decreased 35.1%. Domestic unit sales represented 70.3% of total unit sales for the three months ended June 30, 2026 compared

to 68.9% for the same period last year. The decrease in sales and units was primarily due to the timing of EasyPoint® product

orders from certain customers, which can fluctuate between periods based on customer purchasing patterns.

International revenues for the three months ended

June 30, 2026 decreased 32.2% compared to the same period in 2025. The decrease in international sales was primarily driven by a

decrease in EasyPoint® needle sales. Traditionally, international sales carry lower average selling prices compared to

our domestic sales. There remains uncertainty regarding the timing of future international orders.

Overall, units sales decreased 36.4% due to a

decrease in EasyPoint® needle sales.

Cost of manufactured product decreased 34.7% compared

to the same period last year primarily due to a decrease in sales. Royalty expense decreased 20.8% due to the decrease in gross sales.

Tariffs may continue to materially impact our

costs in future periods. Approximately $46 thousand was spent on tariff expenses in the second quarter of 2026. The reduction in tariff

costs compared to prior periods is attributable to ongoing mitigation efforts, including strategic sourcing decisions and increased domestic

production. These costs are included in Cost of manufactured product.

Operating expenses remained consistent in the

three months ended June 30, 2026 and 2025.

The loss from operations was $5.1 million for

the three months ended June 30, 2026 and 2025.

The unrealized loss on debt securities was $179

thousand for the second quarter of 2026 due to the decreased market values of those securities. The realized gain from the sale of equity

was $6.4 million in the second quarter of 2026.

The provision for income taxes was $1.8 thousand

for the three months ended June 30, 2026 and 2025.

Comparison of Six Months Ended June 30,

2026 and June 30, 2025

Domestic sales accounted for 82.2% and 85.0% of

total revenues for the six months ended June 30, 2026 and 2025, respectively. Domestic revenues decreased 25.8%, while domestic unit

sales decreased 25.0%. Domestic unit sales represented 71.2% of total unit sales for the six months ended June 30, 2026 compared

to 74.9% for the same period last year. The decrease in sales was primarily due to a decrease in EasyPoint® needle unit

sales.

International revenues for the six months ended

June 30, 2026 decreased 9.3% compared to the same period in 2025. Traditionally, international sales carry lower average selling

prices compared to our domestic sales. There remains uncertainty regarding the timing of future international orders.

Overall, units sales decreased 21%.

Cost of manufactured product decreased 20.8% compared

to the same period last year primarily due to a decrease in units sold. Royalty expense decreased 14.4% due to the decrease in gross sales.

Tariffs may continue to materially impact our

costs in future periods. Approximately $58 thousand was spent on tariff expenses in the first six months of 2026. The reduction in tariff

costs compared to prior periods is attributable to ongoing mitigation efforts, including strategic sourcing decisions and increased domestic

production. These costs are included in Cost of manufactured product.

Operating expenses increased 10.0% primarily due

to donation expense.

The loss from operations was $11.3 million compared

to a loss of approximately $9.8 million for the same period last year. The increase in loss from operations was primarily driven by a

decrease in revenue and increase in operating expenses due to donation expense.

The unrealized gain on debt securities was $13

thousand for the six months ended June 30, 2026 due to the increased market values of those securities. The realized gain from the

sale of equity was $6.4 million in the first six months of 2026.

The provision for income taxes was $3.7 thousand

as compared to a benefit for income taxes of $288 thousand for the same period in 2025. The change is primarily due to a decrease in the

net loss in the current period.

ABOUT RETRACTABLE

Retractable manufactures and markets VanishPoint®

and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe,

blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly

from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed

to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable

needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint®

needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general

line distributors.

For more information on Retractable, visit its

website at www.retractable.com.

Forward-looking statements in this press release

are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current

views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate.

However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from

such statements.

Factors that could cause or contribute to such

differences include, but are not limited to: tariffs; material changes in demand; Retractable's ability to maintain liquidity; Retractable's

maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and

relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players in

providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic

reports filed with the U.S. Securities and Exchange Commission.

Retractable Technologies, Inc.

John W. Fort III, 888-806-2626 or 972-294-1010

Vice President, Chief Financial Officer, and Chief

Accounting Officer

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Aug. 14, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Aug. 14, 2026

Entity File Number

001-16465

Entity Registrant Name

Retractable Technologies, Inc.

Entity Central Index Key

0000946563

Entity Tax Identification Number

75-2599762

Entity Incorporation, State or Country Code

Entity Address, Address Line One

511

Lobo Lane

Entity Address, City or Town

Little

Elm

Entity Address, State or Province

Entity Address, Postal Zip Code

75068-5295

City Area Code

972

Local Phone Number

294-1010

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock

Trading Symbol

RVP

Security Exchange Name

NYSEAMER

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration